Rhabdomyosarcoma arising within congenital pulmonary cysts: report of three cases

J J Murphy1, G K Blair, G C Fraser

  • 1Division of Pediatric General Surgery, British Columbia Children's Hospital, Vancouver, Canada.

Insights

Primary pulmonary rhabdomyosarcoma, a rare cancer, can develop within congenital lung cysts. This study highlights the significant risk of rhabdomyosarcoma in malformed lung tissue, emphasizing early detection in pediatric patients.

Area of Science:

  • Pediatric Oncology
  • Pulmonary Medicine
  • Pathology

Background:

  • Primary pulmonary rhabdomyosarcoma is exceptionally rare in children.
  • Congenital lung malformations, such as cystic adenomatoid malformations and bronchogenic cysts, are known to have malignant potential.
  • Early diagnosis of pediatric lung masses is crucial for improved outcomes.

Purpose of the Study:

  • To report three cases of primary pulmonary rhabdomyosarcoma in young children.
  • To investigate the association between congenital lung cysts and the development of pulmonary rhabdomyosarcoma.
  • To raise awareness of the risk of malignancy in pediatric lung cysts.

Main Methods:

  • Case series review of three pediatric patients treated at British Columbia Children's Hospital over 9 months.
  • Clinical presentation, radiographic findings (chest x-ray), and pathological origin of the tumors were analyzed.
  • Histopathological confirmation of rhabdomyosarcoma arising from congenital lung cysts.

Main Results:

  • Three pediatric patients (24-42 months) were diagnosed with primary pulmonary rhabdomyosarcoma.
  • Two patients presented with spontaneous pneumothorax and cystic lung changes; one with chronic cough, fever, and failure to thrive.
  • All three tumors originated within congenital lung cysts: one bronchogenic cyst and two cystic adenomatoid malformations.

Conclusions:

  • There is a significant risk of rhabdomyosarcoma developing within congenital pulmonary malformations.
  • Congenital lung cysts should be considered a potential precursor for pediatric pulmonary rhabdomyosarcoma.
  • Increased vigilance and further research are warranted for early detection and management.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...